Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(6 sites)
Norway
University Hospital of North Norway, Tromsø, Nordland Akershus Hospital:, Oslo, Oslo Haugesund Hospital, Haugesund, Rogaland Stavanger University Hospital, Stavanger, Rogaland St. Olavs Hospital:, Trondheim, Trøndelag Haraldsplass Deaconess Hospital, Bergen, Vestland Age range
50 Years – 100 Years
Last updated October 2024